Trials / Completed
CompletedNCT02412657
Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block
Impact of Two Doses of Intravenous Dexamethasone on the Analgesic Duration of a Single-shot Interscalene Block With Ropivacaine for Shoulder Arthroscopy; a Prospective, Randomized, Placebo-controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Maisonneuve-Rosemont Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Interscalene brachial plexus block provides excellent but time limited analgesia. Intravenous dexamethasone increases the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder arthroscopic surgery. We want to evaluate the effect of two different doses (dexamethasone 10 mg i.v. vs 4 mg i.v. vs placebo) on the analgesic duration of a single-shot inter scalene block. Our study hypothesis is that dexamethasone 4 mg i.v. is equivalent to dexamethasone10 mg i.v. in prolonging the analgesic duration of a single-shot interscalene block with ropivacaine.
Detailed description
75 patients will be randomly assigned to three groups: * D10: dexamethasone 10 mg I.V. diluted in normal saline 20cc, immediately after inter scalene block * D4: dexamethasone 4 mg I.V. diluted in normal saline 20cc, immediately after inter scalene block * C: control: Normal saline 20cc I.V., immediately after inter scalene block. These patient will be recruited from 3 hospitals, with two surgeons performing the surgeries. All patients will have their surgery under regional anesthesia only provided by the inter scalene plexus block, with ropivacaine 0.5% 20cc. In the postoperative period, patients will be given analgesic medication on an as needed basis. They will be instructed to take the first analgesic medication once postoperative shoulder pain has reached \>3/10. They will note the time and day at which this outcome occurs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | After the performance of inter scalene plexus blockade, patients will either receive dexamethasone 10 mg i.v. (diluted with 17.5 mL normal saline), dexamethasone 4 mg i.v. (diluted with 19 mL normal saline), or normal saline 20 ml i.v. |
| DRUG | Normal Saline |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-10-01
- Completion
- 2015-11-01
- First posted
- 2015-04-09
- Last updated
- 2018-09-13
- Results posted
- 2016-04-12
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02412657. Inclusion in this directory is not an endorsement.